Product Images Desvenlafaxine
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 7 images provide visual information about the product associated with Desvenlafaxine NDC 53002-1801 by Rpk Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
structure - image 1
1 - image 2
1 - image 3
This text appears to display data related to the impact of CYP3A4 inhibitors on the maximum concentration (Cmax) of Ketoconazole. It includes geometric mean ratios for the change relative to a reference, with corresponding confidence intervals.*
3 - image 4
figure 4 - image 5
This text appears to be a graph showing the estimated proportion of patients experiencing a relapse over time (in days from randomization) for Desvenlafaxine Extended-Release Tablets 50 mg and Placebo. The y-axis appears to show the percentage of patients experiencing a relapse, with values ranging from 0% to 50% and the x-axis appears to be the number of days from randomization, ranging from 0 to 200.*
figure 5 - image 6
The text represents a graph displaying the estimated proportion of patients with relapse over time (in days from randomization) for a medication called Desvenlafaxine Extended-Release Tablets compared to a placebo. The graph shows that at day 50, the estimated proportion of patients with relapse was around 8% for both the medication and placebo, but the medication showed a lower estimated proportion of patients with relapse (around 3%) at day 150.*
Label Image - lbl530021801
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.